Search Results - "Rzepecki, P."

Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry by Alchi, B, Jayne, D, Labopin, M, Kotova, O, Sergeevicheva, V, Alexander, T, Gualandi, F, Gruhn, B, Ouyang, J, Rzepecki, P, Held, G, Sampol, A, Voswinkel, J, Ljungman, P, Fassas, A, Badoglio, M, Saccardi, R, Farge, D

“…Objectives Patients with systemic lupus erythematosus (SLE) refractory to conventional immunosuppression suffer substantial morbidity and mortality due to…”
Get full text

A Triple-Drug Combination to Prevent Nausea and Vomiting Following BEAM Chemotherapy Before Autologous Hematopoietic Stem Cell Transplantation by Pielichowski, W, Barzal, J, Gawronski, K, Mlot, B, Oborska, S, Wasko-Grabowska, A, Rzepecki, P

“…Abstract Objective We performed a clinical study of a triple-drug combination to evaluate its efficacy to prevent both acute and delayed emesis after high-dose…”
Get full text

Biochemical indices for the assessment of nutritional status during hematopoietic stem cell transplantation: are they worth using? A single center experience by RZEPECKI, P, BARZAL, J, SAROSIEK, T, SZCZYLIK, C

“…Hematopoietic stem cell transplantation (HSCT) is being used increasingly in an attempt to cure many hematological disorders, solid tumors and autoimmune…”
Get full text

The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant by NASILOWSKA-ADAMSKA, B, RZEPECKI, P, DUDA, D, SZYDLO, R, HALABURDA, K, SZCZEPINSKI, A, LANGE, A, HELLMAN, A, ROBAK, T, SKOTNICKI, A, JEDRZEJCZAK, W. W, WALEWSKI, J, MANKO, J, HOLOWIECKI, J, KOMARNICKI, M, DMOSZYNSKA, A, WARZOCHA, K, MARIANSKA, B, CZYZ, A, MARKIEWICZ, M, FEDEROWICZ, I, TOMASZEWSKA, A, PIATKOWSKA-JAKUBAS, B, WRZESIEN-KUS, A, BIENIASZEWSKA, M

“…In this multicenter study, we assessed the use of palifermin (recombinant human-keratinocyte growth factor 1) in the prevention of oral mucositis (OM) and…”
Get full text

Efficiency of Supersaturated Calcium Phosphate Mouth Rinse Treatment in Patients Receiving High-Dose Melphalan or BEAM Prior to Autologous Blood Stem Cell Transplantation: A Single-Center Experience by Waśko-Grabowska, A, Rzepecki, P, Oborska, S, Barzał, J, Gawroński, K, Młot, B, Szczylik, C

“…Abstract Objective Oral mucositis (OM) is an unresolved problem among patients treated with a high-dose therapy supported by hematopoietic stem cell…”
Get full text

Optimization of health-care organization and perceived improvement of patient comfort by switching from intra-venous BU four-times-daily infusions to a once-daily administration scheme in adult hematopoietic stem cell recipients by Xhaard, A, Rzepecki, P, Valcarcel, D, Santarone, S, Fürst, S, Serrano, D, De Angelis, G, Krüger, W, Scheid, C

“…Previous studies have shown an equivalent pharmacokinetic profile between four-times-daily (4QD) and once-daily (QD) administration of intra-venous (IV) BU,…”
Get full text

Hematologic Recovery in Patients Who Are Treated With Autologous Stem Cells Transplantation Taken From Bone Marrow After Granulocyte–Colony-Stimulating Factor Stimulation by Gawronski, K, Rzepecki, P, Oborska, S, Wasko-Grabowska, A

“…Abstract Background We sought to compare hematologic recovery between patients who did or did not receive granulocyte–colony-stimulating factor…”
Get full text

Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients—Report of the Polish Myeloma Group by Usnarska-Zubkiewicz, L, Dębski, J, Butrym, A, Legieć, W, Hus, M, Dmoszyńska, A, Stella-Hołowiecka, B, Zaucha, J.M, Januszczyk, J, Rymko, M, Torosian, T, Charliński, G, Lech-Marańda, E, Malenda, A, Jurczyszyn, A, Urbańska-Ryś, H, Druzd-Sitek, A, Błońska, D, Urbanowicz, A, Hołojda, J, Pogrzeba, J, Rzepecki, P, Hałka, J, Subocz, E, Becht, R, Zdziarska, B, Dytfeld, D, Nowicki, A, Bołkun, Ł, Kłoczko, J, Knopińska-Posłuszny, W, Zubkiewicz-Kucharska, A, Kuliczkowski, K

“…Highlights • Lenalidomide is an effective treatment in RRMM. • ORR increased, reaching 51%, 64% and 68% after 2, 4 and 6 cycles of LEN. • Lenalidomide showed…”
Get full text

Palonosetron in Prevention of Nausea and Vomiting After Highly Emetogenic Chemotherapy Before Haematopoietic Stem Cell Transplantation—Single Center Experience by Rzepecki, P, Pielichowski, W, Oborska, S, Barzal, J, Mlot, B

“…Abstract Objective A clinical study of palonosetron was performed to evaluate its efficacy in preventing both acute and delayed emesis after high-dose…”
Get full text

New Heterocyclic β-Sheet Ligands with Peptidic Recognition Elements by Rzepecki, P, Gallmeier, H, Geib, N, Cernovska, Katarina, König, B, Schrader, T

“…A detailed and comprehensive overview is presented about the design, modeling, and synthesis, as well as spectroscopic characterization, of a new class of…”
Get full text

Which Parameters of Nutritional Status Should We Choose for Nutritional Assessment During Hematopoietic Stem Cell Transplantation? by Rzepecki, P, Barzal, J, Sarosiek, T, Oborska, S, Szczylik, C

“…Abstract Since changes in nutritional indices after hematopoietic stem cell transplantation (HSCT) have not been well studied, there is no definition of risk…”
Get full text

Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry by Alchi, B, Jayne, D, Labopin, M, Demin, A, Sergeevicheva, V, Alexander, T, Gualandi, F, Gruhn, B, Ouyang, J, Rzepecki, P, Held, G, Sampol, A, Voswinkel, J, Ljungman, P, Fassas, A, Badoglio, M, Saccardi, R, Farge, D

Get full text

Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation by Wąsak‐Szulkowska, E., Grabarczyk, P., Rzepecki, P.

“…: Human parvovirus B19 is a very common infectious pathogen in humans. In healthy subjects, B19 infection is the cause of a self‐limiting subclinical erythroid…”
Get full text

Triple drug combination in the prevention of nausea and vomiting following busulfan plus cyclophosphamide chemotherapy before allogeneic hematopoietic stem cell transplantation by Pielichowski, W, Gawronski, K, Mlot, B, Oborska, S, Wasko-Grabowska, A, Rzepecki, P

“…A clinical study of triple drug combination (aprepitant+palonosetron+ dexamethasone) was carried out to evaluate its efficacy in preventing both acute and…”
Get more information

A supersaturated calcium phosphate solution seems to effectively prevent and treat oral mucositis in haematopoietic stem cell transplanted cancer patients - single centre experience by Wasko-Grabowska, A, Rzepecki, P, Oborska, S, Barzal, J, Mlot, B, Gawronski, K, Wasko, M, Szczylik, C

“…Oral mucositis (OM) is one of the most frequent and bothersome complications of high-dose chemotherapy with subsequent auto- and allogeneic haematopoietic stem…”
Get more information

Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experience by Rzepecki, P, Sarosiek, T, Barzal, J, Oborska, S, Nurzynski, P, Wasko, A, Szczylik, C

“…Oral mucositis (OM) is one of the most debilitating and common side effects in patients treated with high-dose chemotherapy supported by haematopoietic stem…”
Get more information

Prevention of Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation with Valganciclovir: Single Center Experience by Rzepecki, P., Barzal, J., Sarosiek, T., Oborska, S., Szczylik, C.

Get full text

How can we help patients with refractory chronic graft versus host disease- single centre experience by Rzepecki, P, Barzal, J, Sarosiek, T, Oborska, S, Szczylik, C

“…Chronic graft-versus-host disease (cGVHD) is a major cause of morbidity and mortality in long-term survivors of allogeneic haematopoietic stem cell…”
Get more information

New Heterocyclic β-Sheet Ligands with Peptidic Recognition Elements by Rzepecki, P., Gallmeier, H., Geib, N., Cernovska, Katarina, König, B., Schrader, T.

Get full text

129P Regulatory dendritic cells correlate with an altered T cell distribution and regulatory T cell phenotype in metastatic lymph nodes of NSCLC patients by Raniszewska, A., Kwiecien, I., Rutkowska, E., Sokolowski, R., Bednarek, J., Rzepecki, P., Domagala-Kulawik, J.

Get full text